Search Results

Filter
  • 1-10 of  30 results for ""Cholesterol Ester Transfer Proteins""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Editorial & Opinion

CETP Inhibitors - A New Inning?

  • Authors : Hegele RA; From the Department of Medicine, Schulich School of Medicine and Dentistry, London, ON, Canada.

Subjects: Anticholesteremic Agents* ; Cholesterol Ester Transfer Proteins*; Cholesterol, HDL

  • Source: The New England journal of medicine [N Engl J Med] 2017 Sep 28; Vol. 377 (13), pp. 1284-1285.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Torcetrapib and coronary events.

Subjects: Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*adverse effects ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*drug therapy ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors

  • Source: The New England journal of medicine [N Engl J Med] 2008 Apr 24; Vol. 358 (17), pp. 1862-3; author reply 1863-4.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Torcetrapib and coronary events.

Subjects: Aldosterone/Aldosterone/Aldosterone/*blood ; Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*adverse effects ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*drug therapy

  • Source: The New England journal of medicine [N Engl J Med] 2008 Apr 24; Vol. 358 (17), pp. 1863; author reply 1863-4.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effect of torcetrapib on the progression of coronary atherosclerosis.

Subjects: Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors ; Cholesterol, HDL/Cholesterol, HDL/Cholesterol, HDL/*blood ; Coronary Artery Disease/Coronary Artery Disease/Coronary Artery Disease/*drug therapy

  • Source: The New England journal of medicine [N Engl J Med] 2007 Mar 29; Vol. 356 (13), pp. 1304-16. Date of Electronic Publication: 2007 Mar 26.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.

Subjects: Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use ; Atherosclerosis/Atherosclerosis/Atherosclerosis/*drug therapy ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors

  • Source: The New England journal of medicine [N Engl J Med] 2017 Sep 28; Vol. 377 (13), pp. 1217-1227. Date of Electronic Publication: 2017 Aug 28.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.

Subjects: Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use ; Benzodiazepines/Benzodiazepines/Benzodiazepines/*therapeutic use ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control

  • Source: The New England journal of medicine [N Engl J Med] 2017 May 18; Vol. 376 (20), pp. 1933-1942.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Dalcetrapib in patients with an acute coronary syndrome.

Subjects: Acute Coronary Syndrome/Acute Coronary Syndrome/Acute Coronary Syndrome/*drug therapy ; Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors

  • Source: The New England journal of medicine [N Engl J Med] 2013 Feb 28; Vol. 368 (9), pp. 869-70.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Dalcetrapib in patients with an acute coronary syndrome.

Subjects: Acute Coronary Syndrome/Acute Coronary Syndrome/Acute Coronary Syndrome/*drug therapy ; Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors

  • Source: The New England journal of medicine [N Engl J Med] 2013 Feb 28; Vol. 368 (9), pp. 869.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Subjects: Acute Coronary Syndrome/Acute Coronary Syndrome/Acute Coronary Syndrome/*drug therapy ; Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors

  • Source: The New England journal of medicine [N Engl J Med] 2012 Nov 29; Vol. 367 (22), pp. 2089-99. Date of Electronic Publication: 2012 Nov 05.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Safety of anacetrapib in patients with or at high risk for coronary heart disease.

Subjects: Anticholesteremic Agents/Anticholesteremic Agents/Anticholesteremic Agents/*therapeutic use ; Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/Cholesterol Ester Transfer Proteins/*antagonists & inhibitors ; Cholesterol, HDL/Cholesterol, HDL/Cholesterol, HDL/*blood

  • Source: The New England journal of medicine [N Engl J Med] 2010 Dec 16; Vol. 363 (25), pp. 2406-15. Date of Electronic Publication: 2010 Nov 17.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  30 results for ""Cholesterol Ester Transfer Proteins""